Trillium Therapeutics Inc (TRIL)

[NY1972]

Pac-Man at Stanford, why P1 stopped at 20??

CD47 clinical trial is small and is not currently recruiting additional patients. As the trial progresses, information about the patients in the trial and the data about how the antibody is performing are kept confidential.

We have over 20 patients enrolled, we have a solid tumor study and an acute myeloid leukemia underway, so we have two different Phase 1’s up and running. They will finish later this year.

http://wxpress.wuxiapptec.com/next-generation-immuno-oncology-creating-new-pathway-eat-cancer-chat-jonathan-macquitty-ceo-forty-seven/